Skip to main content

Translational Development of a Drug Candidate for Neurodegenerative Disorders

Resource type: Grants

Granted to NeuroPath Therapeutics Limited

Goal

To support preclinical development and a first-in-man (Phase I) clinical trial of an attractive drug candidate, discovered at Trinity College Dublin, for potential treatment of neurodegenerative disorders, including ageing-related conditions such as Alzheimer’s disease.

Grant Amount

$9,000,000

Year Awarded

2015

Term

58 Months

Related Resources

Issues:

Aging, Biomedical Research, Knowledge, Research & Innovation

Historical Programme Affiliations:

Founding Chairman